In particular, we observed HIF-1 pathway perturbations to fit the profile of a chronic hypoxia response and also reflect known hallmarks of HIF-1 signaling in lung cancer, including increased anaerobic metabolism and angiogenesis, and suppressed TCA cycle metabolism. The gene discussed is HIF1A; the disease is lung carcinoma.